Glenmark Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Total Qtr Revenue cr
    3,290.88
    3,267.89
    3,418.68
    3,473.21
    3,275.68
    Other Income Qtr Cr26.4411.6831.1339.4231.49
    Operating Revenues Qtr3,264.443,256.213,387.553,433.803,244.19
    Loading chart...
    Operating Expenses Qtr
    2,683.92
    2,695.18
    2,787.32
    2,831.88
    2,655.97
    Operating Profit Qtr
    580.52
    561.02
    600.23
    601.91
    588.21
    EBITDA Qtr Cr
    283.73
    199.89
    631.36
    641.33
    619.70
    Depreciation Qtr
    129.93
    125.20
    122.74
    120.28
    117.79
    Net Profit Qtr
    46.87
    4.65
    347.96
    354.21
    340.27
    Basic EPS Qtr
    1.66
    0.16
    12.33
    12.55
    12.06
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -